Meet-the-Professor Session:
102. Preventing Varicella-Zoster Virus Infections: A Fresh Look at Zoster and Varicella Vaccines in Clinical Practice
Saturday, October 22, 2011: 7:00 AM-8:00 AM
Room: 156ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • relate recent knowledge about immune responses to varicella zoster virus to care of patients eligible for zoster vaccine and varicella vaccine
  • advise patients about safety, immunogenicity, and efficacy of zoster and varicella vaccines

Target Audience: Vaccinologists, Researchers, Pharmacists, Investigators, Infectious Diseases Physicians, Infectious Diseases Pediatricians, Infection Preventionists, Hospital Epidemiologists, HIV Clinicians, Health Care Workers, Clinicians, Academicians

Tracks: Pediatric ID, Adult ID

Meet-the-professors:  Michael N. Oxman, MD, FIDSA, University of California and Anne Gershon, MD, FIDSA, Columbia University College Physicians

CME Credits: Maximum of 1.0 hour of Category 1 credit possible

ACPE Credits: ACPE 1.0 knowledge-based contact hours (0.1 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-087-L01-P

Disclosures:

M. N. Oxman, SANOFI PASTEUR: POSSIBLE SPEAKER ON HIGH-POTENCY INFLUENZA VACCINE FOR OLDER ADULTS, IN LIEU OF HONORARIUM, DONATIN TO SAN DIEGO VETERANS RESEARCH CORPORATION TO SUPPORT RESEARCH

A. Gershon, Merck: Grant Investigator, Grant recipient
GlaxoSmithKline: Consultant, Consulting fee

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.